HRS-7535

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameHRS-7535
Drug Alias NameHRS-7535KAI-7535
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightWeight LossBody Weight Changes +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShandong Shengdi Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesKailera Therapeutics IncHercules CM NewCoShandong Shengdi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightWeight LossBody Weight Changes +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A